INTRODUCTION
It is now generally accepted that cardiac glycosides act by binding to the extracellular face of the sarcolemmal Na ] i per se that effects positive inotropy. This proposed modus operandi is commonly labelled the 'pump-inhibition hypothesis'. 1 Associated with the positive inotropic effect of cardiac glycosides is a potentiation of metabolic rate variously indexed as increased rate of oxygen consumption, 2, 3 increased rate of heat production [4] [5] [6] or diminished concentration of high-energy phosphate compounds. 3, 7 Given the ability of cardiac glycosides to potentiate active (systolic) metabolism, it would not be surprising that they have comparable effects on resting (diastolic) metabolism. Indeed, ouabain-induced metabolic potentiation has been documented in a variety of quiescent cardiac preparations. [8] [9] [10] [11] The putative [Ca 2+ ] i dependence of such potentiation is consistent with both the decrease of extracellular 12 Ca 2+ and the increase of intracellular 10, [13] [14] [15] [16] Ca 2+ that accompanies treatment with various cardiac glycosides. Because the increase in [Ca 2+ ] i is attributed to Na + i -dependent Ca 2+ -influx on the sarcolemmal Na + /Ca 2+ exchanger, it follows that both inotropic and metabotropic effects of cardiac glycosides are expected to depend upon extracellular Ca 2+ concentration. In the case of active cardiac muscle, reliance on [Ca 2+ ] o has been demonstrated. Twitch potentiation by ouabain or strophanthidin in guinea-pig isolated papillary muscles 17 or canine Purkinje fibres 18 is enhanced by elevation of [Ca 2+ ] o . In contrast, superperfusion with Ca
2+
-free solution prevents both the ouabain-induced increase in [Ca 2+ ] i and twitch potentiation in rat isolated cardiac myocytes. 16, 19 Hence, the enhancement of mechanical performance by a cardiac glycoside has been convincingly shown to depend on the presence of extracellular Ca . The mechanism by which cardiac glycosides potentiate cardiac basal metabolism is less clear. The effect of dihydro-ouabain on the rate of heat production of quiescent guinea-pig ventricular trabeculae has been measured using a high-resolution microcalorimetric technique. Introduction of dihydro-ouabain (400 mol/L) led to an initial decrease in heat rate, attributed to inhibition of the Na + /K + -ATPase, 5 followed by a large secondary increase. What is baffling, in view of the pump-inhibition hypothesis detailed above, is that the large secondary increase in heat rate was not prevented by Ca 2+ -free superfusion. 6 This paradoxical result suggests that a glycoside-induced increase in [Na + ] i during cardiac arrest may be capable of inducing a marked increase in metabolic rate through some mechanism that is independent of Ca 2+ influx via Na + /Ca 2+ exchange. In order to clarify this situation, we have performed both experiments and simulations designed to determine whether extracellular Ca 2+ is required for ouabain-induced potentiation of cardiac basal metabolism.
METHODS

Metabolic (whole heart) experiments
Hearts ( n = 26) were isolated from guinea-pigs of either sex (weighing 540-909 g), using methods approved by the University of Auckland Animal Ethics Committee. Hearts were removed quickly and immersed in chilled, oxygenated saline (see below). Hearts were mounted in a Langendorff perfusion apparatus and perfused, at constant flow, as described previously. 20 The glass chamber enclosing the heart was flushed continuously with a stream of humidified gas (5% CO 2 in room air) in order to standardize the rate of exchange of oxygen across the epicardial surface.
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A water-filled latex balloon (Hugo-Sachs Elektronik, March-Hugstetten, Germany) was placed in the left ventricle for measurement of left ventricular pressure ( PLV).
Measurement of oxygen consumption
In preliminary experiments, oxygen consumption was calculated as the product of coronary flow and the arteriovenous difference in oxygen content, as described previously. 22 Coronary flow was measured volumetrically over a period of 2 min. The oxygen content of 50 L samples of perfusate (drawn into air-tight glass Hamilton syringes), from the aortic inflow line and the pulmonary arterial outflow line was measured using an oxygen fuel cell device (OxyCon; Department of Physiology, University of Tasmania, Hobart, Tasmania, Australia).
In subsequent experiments, the rate of oxygen consumption was determined continuously by use of a pair of flow-through Clark-type polarographic PO2 electrodes (Microelectrodes, Londonderry, NH, USA) and a 'drip-counter', as described recently. 20 The 'arterial' electrode was placed immediately upstream of the heart in the aortic cannula and the 'venous' electrode was placed immediately downstream in the catheter draining the right ventricle. The electrodes gave 90% of full response to a step increase of PO2 in 12 s and were calibrated daily using a precision gasmixing pump (Wösthoff, Bochum, Germany). The output of the electrodes was linear in the range 0-100% O2.
Voltage pulses from the drip-counter, together with the amplified output of the PO2 electrodes, were passed to the A/D board (National Instruments, Austin, TX, USA) of a laboratory computer, where on-line analysis was achieved using a program custom-written in Labview software (version 3.1; National Instruments). The program determined the frequency of pulses from the drip-counter and converted this to coronary flow, given that the average size of a drop was linearly related to the mean flow rate. 20 The rate of oxygen consumption (VO2) was calculated continuously as the product of the rate of coronary flow, the arteriovenous difference in partial pressure of oxygen and the solubility of oxygen in the KrebsHenseleit perfusate (0.233 L/mL per kPa). The VO2 is expressed in units of mol/min per gdry, where dry weight was determined following 24 h of desiccation at 70ЊC.
Perfusion solutions
The standard 'low-K + ' or 'beating' solution was a modified KrebsHenseleit bicarbonate buffer containing (in mmol/L): NaCl 118; KCl 4.8; MgSO4 1.18; KH2PO4 1.18; NaHCO3 24.8; CaCl2 2.5; glucose 10. Insulin 
Statistical analyses
Results were analysed by analysis of variance for repeated measures, using procedures available in the SAS statistical software package (SAS Institute, Cary, NC, USA). Differences among means were tested for statistical significance (P < 0.05) using an appropriate set of contrast coefficients. Both graphical and tabular data are expressed as the mean±SEM. The number of animals used was the minimum required to achieve statistical significance, in accord with the policies of the University of Auckland Animal Ethics Committee.
Isolated superfused ventricular trabeculae
In order to examine the intracellular effect of ouabain, we measured [Ca 2+ ]i in isolated trabeculae, at 37ЊC, using a ratiometric spectrofluorometer (Cairn Research, Faversham, Kent, UK). Four trabeculae (two from each ventricle) were isolated from four different guinea-pig hearts in the presence of 20 mmol/L butanedione monoxime and mounted between a monofilament snare and a force transducer (AE-801; SensoNor, Horton, Norway) in an organ bath situated on the stage of an inverted microscope (Nikon Diaphot 300; Nikon Diaphot, Tokyo, Japan). Cells were loaded with the Ca 2+ fluorophore fura-2 in its acetoxylmethyl form; probenecid (1 mmol/L) was used to enhance its retention. Preparations were irradiated with ultraviolet light at 340 and 380 nm and the emitted fluorescence (480-600 nm) captured by a photomultiplier tube. We report relative fluorescence ratios (340/380), calculated after subtraction of autofluorescence.
Mathematical simulations
Simulation of the metabolic cost of the Na + /K + -ATPase, under various perfusion conditions, was achieved using Oxsoft Heart (Oxford Software, Oxford, UK). This software solves the equations developed by DiFrancesco and Noble 23 to model currents associated with ion channels, exchangers and pumps in the heart. We selected it for the following reasons: (i) it contains a module (GPCELL) specific to guinea-pig ventricular myocytes; (ii) the behaviour of its electrogenic Na + /K + pump mimics a wide range of experimental results arising from studies of pump inhibition; (iii) it makes use of the same model equations that Terracciano 24 has recently used to explore the sensitivity of Na 
RESULTS
Metabolic (whole heart) experiments
In order to compare our results with those of Schramm et al., 6 it was necessary to arrest our whole heart preparations. 
Effects of ouabain during KCl arrest
The rate of oxygen consumption of spontaneously contracting, Langendorff-perfused guinea-pig hearts was determined within approximately 15 min of cardiectomy. Hearts were then arrested by elevation of [K + ]o from 6 to 20 mmol/L. As can be seen from the mean (n = 12) data shown in Fig. 1 , the rate of oxygen consumption fell by some 70-80% and remained steady upon induction of arrest. The K + -arrested heart was then subjected to a 10 min period of perfusion with 20 mol/L ouabain and the peak values of oxygen consumption and PLV noted. The means of these peak values are shown in Fig. 1 . Following a subsequent 10 min period of ouabain-free perfusion, [K + ]o was returned to 6 mmol/L, whereupon hearts invariably recommenced beating, albeit at a somewhat reduced rate of energy expenditure (Fig. 1a) . In Fig. 1 (and subsequently) , PLV during low-K + perfusion refers to active (systolic) pressure development, whereas during high-K + perfusion it refers to passive pressure. Note that the latter is extreme in the presence of ouabain, reflecting the development of contracture.
The results shown in Fig. 1 are in accord with the 'delayed increase of heat production' observed by Schramm et al. 6 That is, a brief period of perfusion with 20 mol/L ouabain in the presence of 2.5 mmol/L Ca 2+ o profoundly potentiates the mechanical and metabolic output of the electrically and mechanically quiescent guinea-pig heart, approximating values observed during spontaneous beating. Because low K + recovery was imperfect following ouabain perfusion, in subsequent experiments ouabain perfusion was terminated before full contracture developed.
Effects of Ca
2+
-free perfusion on ouabain-potentiated metabolism during K + arrest
Having established the ability of 20 mol/L ouabain to potentiate the metabolic rate of the K + -arrested heart (Fig. 1) , we performed the critical test of withdrawing extracellular Ca (Fig. 2a) . However, in the absence of Ca 
Effects of ouabain during low Ca 2+ arrest
In order to prove that the null results shown in Fig. 2 were not an artefact of the method of achieving cardiac arrest (elevation of K + ), we induced normokalaemic arrest in the absence of extracellular Ca 2+ in a further two hearts. As can be seen in Fig. 3 , arrest by this means produced the usual 70-80% diminution in rate of oxygen consumption. The subsequent addition of ouabain failed to effect metabolic potentiation. In fact, ouabain caused a statistically significant (P < 0.05), reversible 20% decrement in rate of oxygen consumption during Ca 2+ -free arrest. Note that this result is diametrically opposed to that of Schramm et al., 6 who found the 'delayed increase of heat production' to persist during low-K + superfusion in the absence of extracellular Ca 2+ (1 mmol/L EGTA; pCa > 8; n = 3).
Isolated superfused ventricular trabeculae
Four trabeculae (two from each ventricle) were loaded with the Ca 2+ -sensitive fluorophore fura-2/AM at 37ЊC. Whereas positive inotropy was evident with doses as low as 2 mol/L (data not shown), we routinely applied ouabain at concentrations of 400 mol/L in order to mimic the dosage of dihydro-ouabain used by Schramm et al. 6 in guinea-pig left ventricular trabeculae. As in the preceding whole heart experiments, we examined the effects of ouabain in both the presence and absence of Ca 2+ and under a variety of experimental protocols. In every case in which Ca 
Mathematical modelling
The results of a computer simulation designed to explore the metabolic effect of inhibiting the Na 2+ exchange) such that, by 20 s, an increase in rate of ATP hydrolysis could be detected. The rate of ATP hydrolysis continued to rise to extreme values, driven largely by an increase in actomyosin ATPase activity of the cross-bridges. We do not show corresponding simulations of the effect of pump inhibition in the absence of extracellular Ca 2+ because, in that case, there was no detectable change in 'basal' values of [Ca 2+ ]i, rate of crossbridge cycling or rate of ATP hydrolysis. However, [Na + ]i did increase comparably. Thus, simulation (Fig. 5) of the effects of ouabain in both the presence and absence of extracellular Ca 2+ are in qualitative accord with our experimental measurements of both [Ca 2+ ]i (Fig. 4) and the rate of metabolic energy expenditure (Figs 2,3 ). This concordance is by no means trivial, because it was not explicitly programmed into the Oxsoft Heart software. Rather, it arose implicitly, by solution of a set of differential equations that embody a large number of voltage-and concentration-dependent transmembrane ionic currents. 
DISCUSSION
The widely accepted explanation for the positive inotropic action of cardiotonic steroids, commonly termed the pump inhibition hypothesis, 1 commences with inhibition of the sarcolemmal Na + / K + pump. The resulting increase of intracellular sodium ion concentration effects Na -influx on the sarcolemmal Na + /Ca 2+ exchanger. With the proviso that the primary route of Na + influx becomes Na + leakage channels rather than voltagedependent Na + channels, it is to be expected that the same cellular mechanisms prevail in quiescent myocardium. We tested this proposition by determining the effect of extracellular Ca 2+ on the ability of ouabain to potentiate the rate of oxygen consumption and the development of passive PLV of arrested whole hearts, as well as the intracellular Ca 2+ concentration and passive force development of isolated ventricular trabeculae. The evidence from these two distinct experimental models, bolstered by simulation of the rate of ATP hydrolysis using an established mathematical model, seems incontrovertible. Ouabain stimulation of cardiac resting metabolism requires the presence of extracellular Ca 2+ . This result is at variance with that of Schramm et al., 6 who found that the dihydro-ouabain-induced potentiation of resting heat production of guinea-pig trabeculae was undiminished in the absence of extracellular Ca 2+ . We consider it unlikely that the metabolic discrepancy between our two research groups can be attributed to the difference of cardiac models used in the two studies: superfused left ventricular trabeculae (Schramm et al. 6 ) compared with perfused whole hearts (present study). We would be reluctant to entertain the possibility that preparations of ventricular trabeculae are metabolically unrepresentative of cardiac muscle. In this regard, we discerned no difference in the fura-2 fluorescence responses to ouabain (in either the presence or absence of extracellular Ca 2+ ) between trabeculae dissected from the left and right ventricles. Nor, given the predominantly oxidative nature of cardiac basal metabolism, 25 do we think it likely that the difference in the results could be attributed to the different metabolic indices used: heat production (Schramm et al. 6 ) compared with oxygen consumption (present study).
We consider it equally improbable that our qualitatively different results can be attributed to the different cardiac glycosides used in the two investigations: dihydro-ouabain (Schramm et al. 6 ) compared with ouabain (present study). Whereas these glycosides display different kinetic behaviours and different binding affinities, 26 the relative steady state nature of the metabolic experiments in both investigations renders such kinetic differences less relevant. Any difference of effective concentrations between the two drugs is unlikely to be of importance given that the concentrations chosen in either study were fully effective. That is, 400 mol/L dihydroouabain greatly potentiated the rate of resting heat production of trabeculae, 6 whereas a 20-fold lower concentration of ouabain was equally efficacious in potentiating the rate of resting oxygen consumption of perfused hearts (present study). For this reason, too, the well-documented inhibitory effect of elevated [K + ]o on glycoside binding [27] [28] [29] cannot be invoked as an explanation. Such an effect could only underestimate the potentiating effect of ouabain during 20 mmol/L K + arrest of whole heart preparations. In short, we are unable to reconcile our fundamentally different experimental outcomes.
By way of conclusion, we draw attention to the recent experiments by Reuter et al., 30 who, using myotubes from NCX1-knockout mice, infer that '. . . in embryonic mouse myocytes the Na + / Ca 2+ exchanger is absolutely required for the effect of cardiac glycosides on Ca 2+ i'. Our experimental results, using whole hearts from adult guinea-pigs, are in accord, thereby strengthening our claim that extracellular Ca 2+ is obligatory for ouabain-induced potentiation of cardiac basal energy expenditure. 
